SEC Form 4 · accession 0001437749-18-003651
Sun BioPharma, Inc. · SNBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Kellen
Officer — Chief Financial Officer
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029125
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $8.10 | Feb 27, 2018 | A | 25,000 | A | Feb 27, 2018 | Feb 27, 2028 | Common Stock | 25,000 | 25,000 | D |